2 studies found for:    20400682 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid Leukemia
Conditions: Acute Myelogenous Leukemia;   Myeloid Leukemia in Remission;   Effects of Immunotherapy
Intervention: Biological: Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic (ASCI)
2 Completed Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
Conditions: Leukemia;   Lung Cancer;   Malignant Mesothelioma;   Myelodysplastic Syndromes;   Primary Peritoneal Cavity Cancer
Interventions: Biological: WT-1 analog peptide vaccine;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunoenzyme technique

Indicates status has not been verified in more than two years